arrow
S

Satveer K. Mahil

St John's Institute of Dermatology
H指数:31
被引数:4,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study

评价阿达木单抗在银屑病中的治疗药物监测策略:一项前瞻性药代动力学-药效学研究

2026-04-300
OAAI
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world data

利用慢性斑块状银屑病真实世界数据进行的 risankizumab 药代动力学-药效动力学建模

2026-02-010
OAAI
Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study

银屑病远程监测中的参与度和留存率:mySkin研究的结果

2025-10-290
OAAI
A single-cell and spatial genomics atlas of human skin fibroblasts reveals shared disease-related fibroblast subtypes across tissues

人类皮肤成纤维细胞的单细胞与空间基因组学图谱揭示了跨组织的共享疾病相关成纤维细胞亚型

2025-09-240
OAAI
Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data

开发并验证一种预测别嘌醇诱导严重皮肤不良反应风险的预后模型:一项利用关联的初级保健、住院和死亡数据的回顾性新用户队列研究

2025-09-040
OAAI
P101 Janus kinase inhibitors in palmoplantar pustulosis: a systematic review and meta-analysis of comorbidity burden to inform a feasibility trial's design (JAKPPPOT)

P101 掌跖脓疱病中的Janus kinase抑制剂:一项关于合并症负担的系统评价和荟萃分析,旨在为可行性试验的设计提供信息(JAKPPPOT)

2025-07-010
OAAI
Harnessing artificial intelligence-based image analysis and self-reported data for the assessment of psoriasis severity

利用基于人工智能的图像分析和自报数据对银屑病严重程度进行评估

2025-07-010
OAAI
Response to Lavin et al (2025)’s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System

对Lavin et al (2025)论文的回应:使用Dupilumab后的皮肤T细胞淋巴瘤:一项基于FDA不良事件报告系统的真实世界药物警戒研究

2025-06-300
PRE
Investigating the Genetic Basis of the Influence of Adiposity on Psoriasis: A Cross-Sectional Study in a Large United Kingdom Population–Based Biobank

调查肥胖对银屑病影响遗传基础:一项在英国大型人群为基础的生物银行中的横断面研究

2025-05-270
PRE
Environmental triggers of psoriasis: insights from a UK patient-reported cohort (mySkin)

银屑病的环境触发因素:来自英国患者报告队列(mySkin)的见解

2025-02-250
PRE
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard

银屑病生物制剂疗法的个性化:精准给药仪表盘的开发、验证和用户测试

2025-02-190
OAAI